270 related articles for article (PubMed ID: 28977066)
1. Support vector machine-based classification of neuroimages in Alzheimer's disease: direct comparison of FDG-PET, rCBF-SPECT and MRI data acquired from the same individuals.
Ferreira LK; Rondina JM; Kubo R; Ono CR; Leite CC; Smid J; Bottino C; Nitrini R; Busatto GF; Duran FL; Buchpiguel CA
Braz J Psychiatry; 2018; 40(2):181-191. PubMed ID: 28977066
[TBL] [Abstract][Full Text] [Related]
2. Selecting the most relevant brain regions to discriminate Alzheimer's disease patients from healthy controls using multiple kernel learning: A comparison across functional and structural imaging modalities and atlases.
Rondina JM; Ferreira LK; de Souza Duran FL; Kubo R; Ono CR; Leite CC; Smid J; Nitrini R; Buchpiguel CA; Busatto GF
Neuroimage Clin; 2018; 17():628-641. PubMed ID: 29234599
[TBL] [Abstract][Full Text] [Related]
3. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
Ota K; Oishi N; Ito K; Fukuyama H; ;
J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.
Musiek ES; Chen Y; Korczykowski M; Saboury B; Martinez PM; Reddin JS; Alavi A; Kimberg DY; Wolk DA; Julin P; Newberg AB; Arnold SE; Detre JA
Alzheimers Dement; 2012 Jan; 8(1):51-9. PubMed ID: 22018493
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease.
Kawachi T; Ishii K; Sakamoto S; Sasaki M; Mori T; Yamashita F; Matsuda H; Mori E
Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):801-9. PubMed ID: 16550383
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison study between FDG-PET and IMP-SPECT for diagnosing Alzheimer's disease using 3D-SSP analysis in the same patients.
Nihashi T; Yatsuya H; Hayasaka K; Kato R; Kawatsu S; Arahata Y; Iwai K; Takeda A; Washimi Y; Yoshimura K; Mizuno K; Kato T; Naganawa S; Ito K
Radiat Med; 2007 Jul; 25(6):255-62. PubMed ID: 17634878
[TBL] [Abstract][Full Text] [Related]
7. Head-to-head comparison of cerebral blood flow single-photon emission computed tomography and
Nadebaum DP; Krishnadas N; Poon AMT; Kalff V; Lichtenstein M; Villemagne VL; Jones G; Rowe CC
Intern Med J; 2021 Aug; 51(8):1243-1250. PubMed ID: 32388925
[TBL] [Abstract][Full Text] [Related]
8. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K
Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415
[TBL] [Abstract][Full Text] [Related]
9. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria.
Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H
Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis based SVM classification enables accurate detection of Alzheimer's disease across different clinical centers using FDG-PET and MRI.
Dukart J; Mueller K; Barthel H; Villringer A; Sabri O; Schroeter ML;
Psychiatry Res; 2013 Jun; 212(3):230-6. PubMed ID: 23149027
[TBL] [Abstract][Full Text] [Related]
11. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias.
O'Brien JT; Firbank MJ; Davison C; Barnett N; Bamford C; Donaldson C; Olsen K; Herholz K; Williams D; Lloyd J
J Nucl Med; 2014 Dec; 55(12):1959-65. PubMed ID: 25453043
[TBL] [Abstract][Full Text] [Related]
13. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
Gómez-Río M; Rodríguez-Fernández A; Ramos-Font C; López-Ramírez E; Llamas-Elvira JM
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):966-75. PubMed ID: 18172642
[TBL] [Abstract][Full Text] [Related]
15. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls.
O'Brien JT; Ames D; Desmond P; Lichtenstein M; Binns D; Schweitzer I; Davis S; Tress B
Int Psychogeriatr; 2001 Jun; 13(2):149-61. PubMed ID: 11495391
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
Wei J; Pei S; Zhu X
Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric hippocampal signatures for early diagnosis of Alzheimer's disease using
Chen Z; Bi S; Shan Y; Cui B; Yang H; Qi Z; Zhao Z; Han Y; Yan S; Lu J
CNS Neurosci Ther; 2024 Apr; 30(4):e14539. PubMed ID: 38031997
[TBL] [Abstract][Full Text] [Related]
18. Development of a deep learning network for Alzheimer's disease classification with evaluation of imaging modality and longitudinal data.
Deatsch A; Perovnik M; Namías M; Trošt M; Jeraj R
Phys Med Biol; 2022 Sep; 67(19):. PubMed ID: 36055243
[No Abstract] [Full Text] [Related]
19. Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data.
Samper-González J; Burgos N; Bottani S; Fontanella S; Lu P; Marcoux A; Routier A; Guillon J; Bacci M; Wen J; Bertrand A; Bertin H; Habert MO; Durrleman S; Evgeniou T; Colliot O; ;
Neuroimage; 2018 Dec; 183():504-521. PubMed ID: 30130647
[TBL] [Abstract][Full Text] [Related]
20. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
